Skip to content

PROXYMA

Active
Private limited companyfounded 2020active for 6 yearsSchoon Verblijflaan 4, 1180 Ukkel, BelgiumKBO/BCE: BE 0748.584.632
Summary

PROXYMA has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €202,471 and a net result of €197,500. Equity is growing by about 35% per year across the filed financial years. Its solvency ranks better than 28% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Dental practice
NACE 86230
1 site
Size
≈ €450,000turnover 2025, estimated
Equity
€202,471
Profit
€197,500
Turnover estimated from the gross margin
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 32 days early2 deeds in the Belgian Official Gazette
Why 95lowers riskSector: Human health activities (NACE 86)Size: total assets €610,693Figures for financial year 2025 (filed 29-06-2026)Liquidity: current ratio 1.54, cash €239,334Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 62% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 58-3
equity 33.2% of total assets
Liquidity 77+34
short-term debt 45.5% · cash 39.2%
Profitability 100+17
return on assets 32.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025highest value 08-2025: 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: < 0.1%▼ -0.2 percentage points vs 09-2026lowest value
Credit of up to €19,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.54, compared with 0.39 in 2024, above the usual 1.5; short-term debt: 45.5% and cash: 39.2% of total assets), but 66.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 28% on solvency, 58% on liquidity, 80% on profitability and 83% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €610,693
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 29-06-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.54, cash €239,334
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
32 days early
2024
27 days early
2023
18 days early
2022
32 days late
2021
33 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 2 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 July (4 of the last 5 filed years within 49 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2021 to 2025net €197,500 ▲408%
  3. Liquidity more than triplescurrent ratio 1.54

Financials · financial year 2025, micro format

Turnover
≈ €450,000
Estimated: probably between €400,000 and €560,000
EBIT margin
Not included in this filing
Net result
€197,500▲ 408%
2024 · €38,881
Working capital
€150,672
2024 · -€72,645
Trend over the years

2021 to 2025, 5 financial years

After the dip in 2023 the operating result has climbed two years in a row; 2025 is 5.3 times 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€276,339 2025 Net result€197,500 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20212022202320242025
Operating result€65,759-€58,984▼ 10.3%-€11,776€52,215€276,339▲ 429%
Net result€50,943within the sector's middle half-€46,945within the sector's middle half▼ 7.8%-€14,799below the sector's middle half€38,881within the sector's middle half€197,500above the sector's middle half▲ 408%
Equity€53,943below the sector's middle half-€100,888within the sector's middle half▲ 87.0%€86,090within the sector's middle half▼ 14.7%€124,971within the sector's middle half▲ 45.2%€202,471within the sector's middle half▲ 62.0%
Total assets€80,921below the sector's middle half-€130,786below the sector's middle half▲ 61.6%€305,634within the sector's middle half▲ 134%€348,045within the sector's middle half▲ 13.9%€610,693above the sector's middle half▲ 75.5%
Debt€26,978-€29,898▲ 10.8%€219,544▲ 634%€223,074▲ 1.6%€408,223▲ 83.0%
Working capital€29,725within the sector's middle half-€52,514within the sector's middle half▲ 76.7%-€46,895below the sector's middle half-€72,645below the sector's middle half▼ 54.9%€150,672within the sector's middle half
Solvency66.7%within the sector's middle half-77.1%above the sector's middle half▲ 10.5pp28.2%below the sector's middle half▼ 49.0pp35.9%below the sector's middle half▲ 7.7pp33.2%within the sector's middle half▼ 2.8pp
Current ratio2.10within the sector's middle half-2.76within the sector's middle half▲ 0.650.49below the sector's middle half▼ 2.270.39below the sector's middle half▼ 0.091.54within the sector's middle half▲ 1.15
Return on assets (ROA)63.0%above the sector's middle half-35.9%above the sector's middle half▼ 27.1pp-4.8%below the sector's middle half▼ 40.7pp11.2%within the sector's middle half▲ 16.0pp32.3%within the sector's middle half▲ 21.2pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €610,693
Fixed assets €182,068 ▼ 39.5%
Current assets €428,625 ▲ 811%
Equity and liabilities €610,693
Equity €202,471 ▲ 62.0%
Debt €408,223 ▲ 83.0%
Debt's share of the balance-sheet total rises from 64.1% to 66.8%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€289,725▲
2024 · €120,572
Cash flow
€210,885▲
2024 · €107,239
Debt to equity
2.02▲
2024 · 1.79
ROE
97.5%▲
2024 · 31.1%
Interest coverage
67.64▲
2024 · 28.53
Debt ≤ 1 year
€277,953▲
2024 · €119,702
Debt > 1 year
€130,270▲
2024 · €103,372
Income taxes
€74,559▲
2024 · €10,011
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,782 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 96.7% are still going.

  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.6% went bankrupt
2.7% stopped otherwise
96.7% still going

For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,782 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet Code20242025
Assets
Total assets20/58€348,045€610,693▲
Fixed assets21/28€300,988€182,068▼
Intangible fixed assets21-€47,083
Tangible fixed assets22/27€300,988€124,985▼
Plant, machinery and equipment23€148,322€489▼
Furniture and vehicles24€4,980€107,388▲
Leasing and similar rights25-€17,108
Other tangible fixed assets26€147,686-
Financial fixed assets28-€10,000
Current assets29/58€47,057€428,625▲
Amounts receivable within one year40/41€23,580€186,000▲
Trade receivables40€11,707€186,000▲
Other amounts receivable41€11,872-
Cash at bank and in hand54/58€22,799€239,334▲
Deferred charges and accrued income490/1€678€3,291▲
Equity and liabilities
Total equity and liabilities10/49€348,045€610,693▲
Equity10/15€124,971€202,471▲
Contributions10/11€3,000€3,000=
Profit (loss) carried forward14€121,971€199,471▲
Amounts payable17/49€223,074€408,223▲
Amounts payable after more than one year17€103,372€130,270▲
Financial debts170/4€103,372€130,270▲
Amounts payable within one year42/48€119,702€277,953▲
Current portion of amounts payable after more than one year42€27,104€46,600▲
Trade debts44€37,837€46,044▲
Suppliers440/4€37,837€46,044▲
Taxes, remuneration and social security45€13,761€78,309▲
Taxes450/3€13,761€78,309▲
Other amounts payable47/48€41,000€107,000▲
Income statement Code20242025
Non-recurring operating income76A-€40,044
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€68,358€13,386▼
Other operating charges640/8-€306
Non-recurring operating charges66A€65€63▼
Gross operating margin9900€120,638€290,095▲
Operating profit (loss)9901€52,215€276,339▲
Financial income75/76B€905€3▼
Recurring financial income75€905€3▼
Financial charges65/66B€4,227€4,284▲
Recurring financial charges65€4,227€4,284▲
Profit (loss) for the period before taxes9903€48,893€272,058▲
Income taxes67/77€10,011€74,559▲
Profit (loss) for the period9904€38,881€197,500▲
Profit (loss) for the period to be appropriated9905€38,881€197,500▲
Appropriation of the result
Profit (loss) to be appropriated9906€121,971€319,471▲
Profit (loss) brought forward from the previous period14P€83,090€121,971▲
Profit to be distributed694/7-€120,000
Return on contributions (dividend)694-€120,000

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A----€40,044-
Remuneration, social security and pensions62€2,970€1,920€1,760---
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,574€9,212€40,672€68,358€13,386▼ 80.4%
Other operating charges640/8€397€398€529-€306-
Non-recurring operating charges66A---€65€63▼ 3.1%
Gross operating margin9900€72,700€70,513€31,186€120,638€290,095▲ 140%
Operating profit (loss)9901€65,759€58,984-€11,776€52,215€276,339▲ 429%
Financial income75/76B€1€241€711€905€3▼ 99.7%
Recurring financial income75€1€241€711€905€3▼ 99.7%
Financial charges65/66B€334€949€3,733€4,227€4,284▲ 1.3%
Recurring financial charges65€334€949€3,733€4,227€4,284▲ 1.3%
Profit (loss) for the period before taxes9903€65,426€58,277-€14,799€48,893€272,058▲ 456%
Income taxes67/77€14,483€11,331-€10,011€74,559▲ 645%
Profit (loss) for the period9904€50,943€46,945-€14,799€38,881€197,500▲ 408%
Profit (loss) for the period to be appropriated9905€50,943€46,945-€14,799€38,881€197,500▲ 408%
Line20212022202320242025Change
Assets
Total assets20/58€80,921€130,786€305,634€348,045€610,693▲ 75.5%
Fixed assets21/28€24,219€48,374€261,371€300,988€182,068▼ 39.5%
Intangible fixed assets21----€47,083-
Tangible fixed assets22/27€24,219€48,374€261,371€300,988€124,985▼ 58.5%
Plant, machinery and equipment23€24,219€43,563€198,096€148,322€489▼ 99.7%
Furniture and vehicles24--€6,423€4,980€107,388▲ 22×
Leasing and similar rights25----€17,108-
Other tangible fixed assets26-€4,811€56,852€147,686--
Financial fixed assets28----€10,000-
Current assets29/58€56,703€82,412€44,263€47,057€428,625▲ 811%
Amounts receivable within one year40/41-€10,349€16,356€23,580€186,000▲ 689%
Trade receivables40---€11,707€186,000▲ 16×
Other amounts receivable41-€10,349€16,356€11,872--
Cash at bank and in hand54/58€56,703€54,048€16,883€22,799€239,334▲ 950%
Deferred charges and accrued income490/1-€18,015€11,024€678€3,291▲ 385%
Equity and liabilities
Total equity and liabilities10/49€80,921€130,786€305,634€348,045€610,693▲ 75.5%
Equity10/15€53,943€100,888€86,090€124,971€202,471▲ 62.0%
Contributions10/11€3,000€3,000€3,000€3,000€3,000=
Capital10€3,000€3,000€3,000---
Issued capital100€3,000€3,000€3,000---
Profit (loss) carried forward14€50,943€97,888€83,090€121,971€199,471▲ 63.5%
Amounts payable17/49€26,978€29,898€219,544€223,074€408,223▲ 83.0%
Amounts payable after more than one year17--€128,386€103,372€130,270▲ 26.0%
Financial debts170/4--€128,386€103,372€130,270▲ 26.0%
Amounts payable within one year42/48€26,978€29,898€91,158€119,702€277,953▲ 132%
Current portion of amounts payable after more than one year42--€25,261€27,104€46,600▲ 71.9%
Trade debts44€5,154€1,040€65,072€37,837€46,044▲ 21.7%
Suppliers440/4€5,154€1,040€65,072€37,837€46,044▲ 21.7%
Taxes, remuneration and social security45€18,476€28,858€825€13,761€78,309▲ 469%
Taxes450/3€18,476€28,858€825€13,761€78,309▲ 469%
Other amounts payable47/48€3,349--€41,000€107,000▲ 161%
Line20212022202320242025Change
Profit (loss) for the period9904€50,943€46,945-€14,799€38,881€197,500▲ 408%
+ Depreciation and write-downs630€3,574€9,212€40,672€68,358€13,386▼ 80.4%
Operating cash flow (approximation)€54,518€56,157€25,874€107,239€210,885▲ 96.7%
Investment in fixed assets (approximation)--€33,367-€253,669-€107,975€105,534-
Change in cash--€2,654-€37,165€5,916€216,535▲ 37×

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (5)
Financial year Type Filed Reference
31-12-2025 micro format 29-06-2026 2026-00211342
31-12-2024 micro format 04-07-2025 2025-00228849
31-12-2023 micro format 13-07-2024 2024-00241873
31-12-2022 full format 01-09-2023 2023-00410774
31-12-2021 micro format 02-09-2022 2022-20425968

Similar companies · same sector, comparable size

Of the 6,943 active companies whose main activity is dental practice (NACE 86230), figures are known for 4,370. 3,831 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 2 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

Group and network

Connections & network

1 connected company
Depth

The connected companies are in the list below.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
Studio Dental Lab
Shared director
→

History

PROXYMA was incorporated on 15 June 2020 as a private limited company.1 Total assets rose from €80,921 in 2021 to €610,693 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2021 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
29-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Highest result from 2021 to 2025net €197,500 ▲408%
Operating result €276,339, net result €197,500, both a record.
31-12
Financial Liquidity more than triplescurrent ratio 1.54
Current ratio from 0.39 to 1.54.
31-12
Financial Equity above €200,000equity €202,471 ▲62%
2 profitable years in a row build equity to €202,471.
04-07
NBB filing Annual accounts filed
financial year 2024 · micro format
24-03
Gazette deed Founder · Incorporation
Founding capital · Bank account
2024
31-12
Financial Back to profitnet €38,881
Net result €38,881 after one loss-making year.
31-12
Financial Equity above €100,000equity €124,971 ▲45.2%
Equity rises from €86,090 to €124,971.
13-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Weakest financial yearnet -€14,799
Net result drops to -€14,799, the lowest in the series; recovery starts the following year.
01-09
NBB filing Annual accounts filed
financial year 2022 · full format · 32 days late
2022
31-12
Financial Equity above €100,000equity €100,888 ▲87%
A profit in every financial year since 2021 builds equity to €100,888.
02-09
NBB filing Annual accounts filed
financial year 2021 · micro format · 33 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts

We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded15-06-2020
Financial year end31-12
Activities, NACEBEL 2025
86230Dental practice
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0748584632
Registered 12-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Legal Entity Identifier

254900C6XNCQA7N17C54
no longer live in the LEI register

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2020
registered office establishment The establishment unit on the map
Ground area
407 m²
Building footprint
245 m²
Building volume
3,208 m³
2 parcels, Brussels · tallest building 19.8 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
PROXYMA
Edmond Mesenslaan 86, 1040 EtterbeekDental practice
since 2020unit no. 2.314.919.054
2 parcels
Brussels 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
21363B0318/00F011 Brussels 307 m² 1 · 143 m² 13.1 m · 4
21612C0057/00V000 Brussels 100 m² 1 · 102 m² 19.8 m · 6
How the parcels are linked
Good to know
Both parcels match the address exactly.